Inflammasomes as mediators of immunity against influenza virus

Trends in Immunology

Volumn 32, Issue 1, 2011, Pages 34-41

  Pang, Iris K ^a   Iwasaki, Akiko ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 7;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; CYTOKINE PRODUCTION; HUMAN; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NONHUMAN; REVIEW; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE;

EID: 78650754831     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.11.004     Document Type: Review

References (72)

1. Ballesteros-Tato A., et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza. Nat. Immunol. 2010, 11:216-224.
2. McGill J., et al. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 2008, 205:1635-1646.
3. Roman E., et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 2002, 196:957-968.
4. Kohlmeier J.E., Woodland D.L. Immunity to respiratory viruses. Ann. Rev. Immunol. 2009, 27:61-82.
5. Pichlmair A., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
6. Lund J.M., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5598-5603.
7. Diebold S.S., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
8. Kato H., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
9. Le Goffic R., et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 2007, 178:3368-3372.
10. Guillot L., et al. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 2005, 280:5571-5580.
11. Le Goffic R., et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006, 2:e53.
12. Lopez C.B., et al. TLR-independent induction of dendritic dell maturation and adaptive immunity by negative-strand RNA viruses. J. Immunol. 2004, 173:6882-6889.
13. Heer A.K., et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 2007, 178:2182-2191.
14. Koyama S., et al. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 2007, 179:4711-4720.
15. Ichinohe T., et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
16. Thomas P.G. et al. (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. 30, 566-75.
17. Allen I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
18. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Ann. Rev. Immunol. 2009, 27:519-550.
19. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
20. Yu H.B., Finlay B.B. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 2008, 4:198-208.
21. Martinon F., Tschopp NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 2005, 26:447-454.
22. Kanneganti T.-D., et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006, 281:36560-36568.
23. Kanneganti T.-D., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236.
24. Muruve D.A., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452:103-107.
25. Poeck H., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1b production. Nat. Immunol. 2010, 11:63-69.
26. Rathinam V.A.K., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11:395-402.
27. Roberts T.L., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
28. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
29. Fernandes-Alnemri T., et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
30. Burckstummer T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 2009, 10:266-272.
31. Fernandes-Alnemri T., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 2010, 11:385-393.
32. Pirhonen J., et al. Virus infection activates IL-1β and IL-18 production in human macrophages by a zaspase-1-dependent pathway. J. Immunol. 1999, 162:7322-7329.
33. Ichinohe T., et al. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010, 11:404-410.
34. Bauernfeind F.G., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
35. Franchi L., et al. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009, 183:792-796.
36. Martinon F., et al. The inflammasomes: guardians of the body. Ann. Rev. Immunol. 2009, 27:229-265.
37. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 2010, 10:210-215.
38. Schroder K., et al. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
39. Hornung V., Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010, 40:620-623.
40. Pinto L.H., Lamb R.A. The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 2006, 281:8997-9000.
41. Takeda M., et al. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 2002, 76:1391-1399.
42. Zhirnov O.P. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 1990, 176:274-279.
43. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 1991, 67:117-130.
44. Ciampor F., et al. Evidence that the amantadine-induced. M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology 1992, 188:14-24.
45. Sakaguchi T., et al. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J. Cell Biol. 1996, 133:733-747.
46. Leiding T., et al. Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15409-15414.
47. Wang K. et al. (2010) Viral proteins function as ion channels. Biochim Biophys Acta (in press).
48. Schubert U., et al. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Letters 1996, 398:12-18.
49. Pontillo A., et al. A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 2010, 54:236-240.
50. Watanabe S., et al. Influenza A virus lacking M2 protein as a live attenuated vaccine. J. Virol. 2009, 83:5947-5950.
51. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
52. Acosta-Rodriguez E.V., et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
53. Ben-Sasson S.Z., et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7119-7124.
54. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
55. French A.R., et al. IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation. Cytokine 2006, 35:229-234.
56. Takeda K., et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998, 8:383-390.
57. Hyodo Y., et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 1999, 162:1662-1668.
58. Hoshino T., et al. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 2001, 166:7014-7018.
59. Okamura H., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
60. Schmitz N., et al. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 2005, 79:6441-6448.
61. Liu B., et al. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2004, 85:423-428.
62. Denton A., et al. IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. Eur. J. Immunol. 2007, 37:368-375.
63. Rodrigue-Gervais I.G., Saleh M. Genetics of inflammasome-associated disorders: A lesson in the guiding principles of inflammasome function. Eur. J. Immunol. 2010, 40:643-648.
64. Hise A.G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
65. Lev-Sagie A., et al. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 2009, 200. p. 303e1-6.
66. Witkin S.S., et al. Genetic polymorphism in an inflammasome component, cervical mycoplasma detection and female infertility in women undergoing in vitro fertilization. J. Reprod. Immunol. 2010, 84:171-175.
67. Saleh M., et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004, 429:75-79.
68. Wilkinson R.J., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J. Exp. Med. 1999, 189:1863-1874.
69. Witkin S.S., et al. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin. Infect. Dis. 2002, 34:204-209.
70. Broz P., et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 2010, 207:1745-1755.
71. Wang L., et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase-1-dependent cytokine processing. J. Biol. Chem. 2002, 277:29874-29880.
72. Martinon F., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol. Cell 2002, 10:417-426.